The effect of medication adherence on health care utilization in bipolar disorder

Managed Care Interface

Volumn 19, Issue 9, 2006, Pages 41-46

  Lew, Kim H ^a   Chang, Eunice Y ^a   Rajagopalan, Krithika ^b   Knoth, Russell L ^a  

^a Prescription Solutions   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; HYPNOTIC SEDATIVE AGENT; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OXCARBAZEPINE; PSYCHOTROPIC AGENT; VALPROIC ACID;

ADULT; AGE; AGED; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; EMERGENCY WARD; FEMALE; GENDER; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENTAL HEALTH; PATIENT COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIPOLAR DISORDER; FEMALE; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 33749168380     PISSN: 10965645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bipolar Disorder. National Institutes of Health publication No. (NIH) 002-3679, Bethesda, MD, National Institute of Mental Health, National Institutes of Health, U.S. Department of Health and Human Services, 2001.
2. The World Health Report, 2001: Mental Health - New Understanding, New Hope. Geneva, Switzerland, World Health Organization, 2001.
3. Knoth RL, Chen K, Tafesse E: Data points: Costs associated with the treatment of patients with bipolar disorder in a managed care organization. Psychiatr Serv 2004;55:1353.
4. Bryant-Comstock L, Stender M, Devercelli G: Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002;4:398-405.
5. Lish JD, Dime-Meenan S, Whybrow PC, et al: The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. J Affect Dis 1994;31:281-294.
6. Narrow WE, Regier DA, Rae DS, et al: Use of services by persons with mental and addictive disorders. Findings from the National Institute of Mental Health Epidemiologic Catchment Area Program. Arch Gen Psychiatry 1993;50:95-107.
7. Sachs GS, Printz DJ, Kahn DA, et al: The expert consensus guideline series: Medication treatment of bipolar disorder 2000. Postgrad Med 2000;(April):1-104.
8. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(suppl 4):1-50.
9. Scott J, Pope M: Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 2002;159:1927-1929.
10. Svarstad BL, Shireman TI, Sweeney JK: Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001;52:805-811.
11. Keck PE Jr, McElroy SL, Strakowski SM, et al: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998;155:646-652.
12. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987;40:373-383.
13. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
14. Li J, McCombs JS, Stimmel GL: Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program. J Affect Disord 2002;71:131-139.
15. Birnbaum HG, Shi L, Dial E, et al: Economic consequences of not recognizing bipolar disorder patients: A cross-sectional descriptive analysis. J Clin Psychiatry 2003;64:1201-1209.
16. Eaddy M, Grogg A, Locklear J: Assessment of compliance with antipsychotic treatment and resource utilization in a Medicaid population. Clin Ther 2005;27:263-272.
17. Perlick DA, Rosenheck RA, Kaczynski R, et al: Medication non-adherence in bipolar disorder: A patient-centered review of research findings. Clin Approaches Bipolar Disord 2004;3:56-64.
18. Colom F, Vieta E: Treatment adherence in bipolar patients. Clin Approaches Bipolar Disord 2002;1:49-56.
19. Keck PE Jr, McElroy SL, Stratkowski SM, et al: Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997;33:87-91.
20. Morselli PL, Elgie R: GAMIAN-Europe/BEAM survey I - global analysis of a patient questionnaire circulated to 3450 members of 12 European advocacy groups operating in the field of mood disorders. Bipolar Disord 2003;5:265-278.
21. Colom F, Vieta E, Martinez-Aran A, et al: Clinical factors associated with treatment noncompliance in euthymic bipolar disorder patients. J Clin Psychiatry 2000;61:549-555.